Cogent Biosciences, Inc. COGT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$354.3M-31.5% | -$328.94M-28.6% | -$294.37M-21.5% | -$284.08M-25.1% | -$269.5M-27.0% | ||
| $2.55M+2.4% | $2.56M+4.7% | $2.56M+5.7% | $2.54M+6.5% | $2.49M+6.5% | ||
| $52.98M+31.3% | $46.08M+16.0% | $40.31M+4.4% | $40.06M+8.2% | $40.36M+18.1% | ||
| -$284.82M-28.4% | -$264.44M-27.3% | -$245.92M-28.6% | -$233.61M-31.8% | -$221.77M-33.1% | ||
| $1.46M+38.7% | $1.55M+171% | $818K+0.6% | $1.03M+58.0% | $1.05M-40.4% | ||
| -$505.36M-574% | -$399.53M-1,144% | -$15.09M— | $200.15M— | $106.61M— | ||
| —— | $54.64M— | $40.98M— | $27.32M— | $13.66M— | ||
| $905.8M+3,436% | $878.23M+309% | $289.59M+34.9% | $72.85M-66.1% | $25.62M-93.2% | ||
| $117.59M— | $216.23M— | $30.55M— | $39.38M— | —— | ||
| -$286.27M-28.5% | -$266M-27.7% | -$246.73M-28.4% | -$234.65M-31.9% | -$222.82M-32.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cogent Biosciences, Inc. generate?
- Cogent Biosciences, Inc. (COGT) generated -$284.8M in operating cash flow over the trailing twelve months.
- What is Cogent Biosciences, Inc.'s free cash flow?
- After $1.5M of capital expenditures, Cogent Biosciences, Inc.'s free cash flow was -$286.3M over the trailing twelve months, down 28.5% year over year.
- Where does Cogent Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
